Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates.

Núñez, Kelley G; Sandow, Tyler; Patel, Jai; Hibino, Mina; Fort, Daniel; Cohen, Ari J; Thevenot, Paul

Núñez, Kelley G; Sandow, Tyler; Patel, Jai; Hibino, Mina; Fort, Daniel; Cohen, Ari J; Thevenot, Paul.

Afiliação

Núñez KG; Institute of Translational Research, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Sandow T; Department of Radiology, Ochsner Health, New Orleans, LA 70121, USA.
Patel J; Institute of Translational Research, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Hibino M; Institute of Translational Research, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Fort D; Center for Outcomes Research, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Cohen AJ; Institute of Translational Research, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Thevenot P; Multi-Organ Transplant Institute, Ochsner Health, New Orleans, LA 70121, USA.

Cancers (Basel) ; 14(7)2022 Mar 25.

Article em En | MEDLINE | ID: mdl-35406456

Palavras-chave

HCC; albumin; liver transplantation; liver-directed therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google